Webinar: Surrogate Outcomes in Health Technology Assessment - Accelerating Access to Breakthrough Treatments

Surrogate outcomes play an important role in modern healthcare research. They act as an early indicator of treatment efficacy, where measurement of clinically meaningful outcomes would require long-term follow-up. Using surrogate endpoints in clinical trials may allow earlier market approval of new drugs and faster patient access to innovative and more effective treatments. However, health technology assessment (HTA) processes—which govern access to treatments in many countries—require prediction of clinically meaningful outcomes to evaluate the value to patients. 

Join us for this webinar where our experts will focus on methods and guidelines for establishing surrogate outcomes and how they have been used in HTAs.

Participants can expect to:

1. Gain an understanding of what surrogate outcomes are and their importance in healthcare research
2. Learn about surrogate analysis methods and HTA guidance
3. Explore real-world examples and challenges around using surrogate outcomes in HTAs, with examples in cardiovascular disease, oncology, and obesity
4. Assimilate learnings for future use of surrogates in HTA submissions